BN Business News
기업 추가 →
이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.

에너지 및 환경 · 1995. 1. 4.1 분 읽기

Preparation, Transfer for Commercial Distribution, and Use of Byproduct Material for Medical Use

로컬 자동 번역 · 원본 출처 언어

요약

The Nuclear Regulatory Commission (NRC) is amending regulatory text and the response to a public comment contained in a final rule published in the Federal Register on Friday, December 2, 1994, entitled "Preparation, Transfer for Commercial Distribution, and Use of Byproduct Material for Medical Use." This action is necessary following reconsideration by the NRC regarding the requirements for the information to be included on labels for radioactive drugs to be transferred for commercial distribution. The effect of this action is to reduce regulatory burden and uncertainty for licensees that manufacture and distribute radiopharmaceuticals that contain byproduct material for medical use.

원본 출처 언어: Federal Register — Nuclear Regulatory Commission원문 발표 열기 →